Jan 17, 2024
Dr. Steve Marcus, CEO of Cantex Pharmaceuticals, emphasizes the importance of the RAGE receptor in diseases like cancer and inflammation. Their lead compound, azeliragon, blocks the activation of the RAGE receptor and shows effectiveness in inhibiting cancer metastasis and enhancing the impact of radiation. Clinical...
Jan 17, 2024
Dr. Steve Marcus, CEO of Cantex Pharmaceuticals, emphasizes the importance of the RAGE receptor in diseases like cancer and inflammation. Their lead compound, azeliragon, blocks the activation of the RAGE receptor and shows effectiveness in inhibiting cancer metastasis and enhancing the impact of radiation. Clinical...
Dec 14, 2023
Dr. Ruben Mesa, Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, discusses advancements in the treatment of myelofibrosis, chronic leukemia, a blood cancer characterized by scarring in the bone marrow. Current therapies include stem cell transplants and ruxolitinib, a drug that helps...
Dec 14, 2023
Dr. Ruben Mesa, Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, discusses advancements in the treatment of myelofibrosis, chronic leukemia, a blood disease characterized by scarring in the bone marrow. Current therapies include stem cell transplants and ruxolitinib, a drug that helps...
Nov 30, 2023
Dr. Todd Sachs, Chief Medical Officer at AccessHope, highlights why socioeconomic disparities in cancer mortality have widened. The key is access to screening tests, often limited by the cost and location of the testing facility. Geography also impacts access to sub-specialists with the most current...